Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015894

Options or other derivatives

  • President and CEO acquired 384,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Walker Neal President and CEO 2019-03-01 Grant or award · Restricted stock units +384,600 384,600 D
Loading xslF345X03/doc4.xml…